Loading...
XSHE
300813
Market cap587mUSD
Oct 10, Last price  
34.56CNY
1D
-3.33%
1Q
65.91%
IPO
147.37%
Name

Zhejiang Tailin Bioengineering Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
320.95
P/S
12.00
EPS
0.11
Div Yield, %
0.29%
Shrs. gr., 5y
0.12%
Rev. gr., 5y
14.04%
Revenues
349m
+29.33%
94,463,28559,499,81482,332,546111,760,610142,018,123159,097,741180,928,327200,237,532283,248,491373,878,114269,856,059348,998,253
Net income
13m
-33.65%
21,456,57110,122,08915,372,39329,016,35944,987,87948,214,58934,406,39148,385,61363,529,85179,686,20219,668,95013,050,671
CFO
25m
+1,176.30%
11,512,35917,508,48524,540,41831,563,27023,043,84637,326,17329,039,126106,282,84535,961,76989,385,6191,931,88424,656,614
Dividend
May 27, 20240.1 CNY/sh

Profile

Zhejiang Tailin BioEngineering Co.,Ltd manufactures microbial test and control equipment, mainly for pharmaceutical and medical sector. The company offers sterility testing equipment, microbiological testing equipment, TOC analyzers, sterile isolation systems, hydrogen peroxide sterilization systems, sterile delivery system, and filters, as well as technical services. Its products are primarily used in bio-pharmaceutical, medical, disease control, food, environmental protection, electronics, and other fields, as well as in bio-security equipment manufacturing industries. The company was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. Zhejiang Tailin BioEngineering Co.,Ltd was founded in 1993 and is based in Hangzhou, China.
URL
http://www.tailingood.com/
IPO date
Jan 14, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
348,998
29.33%
269,856
-27.82%
373,878
32.00%
Cost of revenue
285,138
247,406
295,851
Unusual Expense (Income)
NOPBT
63,860
22,450
78,027
NOPBT Margin
18.30%
8.32%
20.87%
Operating Taxes
513
3,531
261
Tax Rate
0.80%
15.73%
0.33%
NOPAT
63,347
18,919
77,766
Net income
13,051
-33.65%
19,669
-75.32%
79,686
25.43%
Dividends
(27,172)
(15,591)
Dividend yield
0.96%
0.39%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,670
1,532
Long-term debt
157,589
145,467
Deferred revenue
(412)
Other long-term liabilities
1
412
Net debt
(269,348)
(243,393)
(452,209)
Cash flow
Cash from operating activities
24,657
1,932
89,386
CAPEX
(18,538)
(176,242)
Cash from investing activities
(42,380)
(172,344)
Cash from financing activities
(10,463)
(13,583)
183,849
FCF
(87,086)
(160,604)
48,651
Balance
Cash
264,873
396,983
577,154
Long term investments
8,145
4,000
22,054
Excess cash
255,567
387,490
580,514
Stockholders' equity
372,593
456,077
449,745
Invested Capital
568,832
420,339
337,750
ROIC
12.81%
4.99%
27.49%
ROCE
7.71%
2.77%
9.90%
EV
Common stock shares outstanding
108,756
115,700
112,600
Price
17.27
-29.57%
24.52
-31.39%
35.74
-25.66%
Market cap
1,878,209
-33.79%
2,836,957
-29.50%
4,024,153
-22.57%
EV
1,609,541
2,595,040
3,571,944
EBITDA
80,454
36,858
91,351
EV/EBITDA
20.01
70.41
39.10
Interest
15,024
621
882
Interest/NOPBT
23.53%
2.76%
1.13%